公司资料
Teleflex 股价、新闻与催化剂
- 股票代码:
- TFX
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
133.07 USD (-2.99%)
收盘价
最后更新: 2026年8月17日
5.54B USD
市值
股价为何变动
As of Aug 17, 2026, TFX closed down 2.99% at $133.07. No new same-company headline was identified in the current news window.
公司概览
业务概览
Teleflex is a medical technology company with products across anesthesia, vascular access, interventional, and surgical care. Its business is centered on procedure-linked devices used across acute care and hospital settings.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Teleflex has a global medtech footprint. It sits in medical devices rather than biotech or pharma.
商业模式特征
The company generates revenue through device sales, consumables, and procedure-related products. Investors focus on hospital demand, product mix, supply execution, and margin trends.
生物医药行业定位
Teleflex is outside biotech but important in healthcare technology because it serves procedure-driven clinical workflows. Its stock is driven by device adoption and hospital utilization, not trial data.
未来催化剂
- Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。